Roxana Dronca

13.7k citations
113 papers · 3.9k · 1 hit paper · h-index 33

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cutaneous Melanoma Detection and Management
  • Immunology top 2%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • Cancer Immunotherapy and Biomarkers 47
    • CAR-T cell therapy research 35
    • Cutaneous Melanoma Detection and Management 19
    • Immunotherapy and Immune Responses 30
    • Immune Cell Function and Interaction 6

Roxana Dronca

102 papers receiving 3.8k citations

Roxana Dronca's Hit Papers

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 2019 · 659 citations
6590+2+4Years since publication200400600

Peers

Roxana Dronca
Comparison fields: 5 of 105
  • Oncology 2.5k
  • Immunology 1.2k
  • Pulmonary and Respiratory Medicine 581
  • Ophthalmology 135
  • Cancer Research 227
Replace Michele Del Vecchio with:
Michele Del Vecchio Italy
Elizabeth I. Buchbinder United States
Maresa Altomonte Italy
Hussein A. Tawbi United States
Salvador Martín‐Algarra Spain
Renata Ferrarotto United States
Ragini R. Kudchadkar United States
Luana Calabrò Italy
Thomas Olencki United States
Pier Francesco Ferrucci Italy
Roxana Dronca relative to Michele Del Vecchio Italy Michele Del Vecchio's profile →
Citations per field
00.5×1.5×1.8×
Michele Del Vecchio · 1×
Citations per year

Countries citing papers authored by Roxana Dronca

Since Specialization
Citations

This map shows the geographic impact of Roxana Dronca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxana Dronca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxana Dronca more than expected).

Fields of papers citing papers by Roxana Dronca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxana Dronca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxana Dronca. The network helps show where Roxana Dronca may publish in the future.

Co-authors

The 25 scholars most cited alongside Roxana Dronca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roxana Dronca Line = papers co-authored together Roxana Dronca links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
Hit paper breakdown →
2019659
2 2017346
3 2016265
4 2018186
5 2019111
6 2014109
7 2017105
8 2019103
9 2018101
10 201789
11 202086
12 201684
13 201678
14 201478
15 201476
16 201570
17 201266
18 201866
19 201359
20 201658

About Roxana Dronca

Roxana Dronca is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 113 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (47 papers), CAR-T cell therapy research (35 papers), Immunotherapy and Immune Responses (30 papers), Cutaneous Melanoma Detection and Management (19 papers), Melanoma and MAPK Pathways (18 papers), Cancer Genomics and Diagnostics (7 papers), Prostate Cancer Treatment and Research (6 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Oncology (2.5k citations), Immunology (1.2k citations), Pulmonary and Respiratory Medicine (581 citations), Ophthalmology (135 citations) and Cancer Research (227 citations). Roxana Dronca has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Svetomir N. Markovic, Haidong Dong, Aaron S. Mansfield, Omid Hamid, F. Stephen Hodi, Adil Daud, Richard Kefford, Jeffrey S. Weber, Anthony M. Joshua and Jedd D. Wolchok. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Melanoma Research, Mayo Clinic Proceedings and Cancer Epidemiology Biomarkers & Prevention.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact